EGFR and lung cancer: Although the development of brain metastases in general predicts a poor outcome in lung cancer, it is not known whether EGFR mutation-positive patients with brain metastases have a better prognosis as compared to EGFR mutation-negative patients, especially those in stages I to III lung cancer.